273 related articles for article (PubMed ID: 11782423)
1. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
Craig E; Zhang ZK; Davies KP; Kalpana GV
EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2.
Kumari G; Mahalingam S
Exp Cell Res; 2009 Oct; 315(16):2775-90. PubMed ID: 19555684
[TBL] [Abstract][Full Text] [Related]
4. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells.
Reincke BS; Rosson GB; Oswald BW; Wright CF
J Cell Physiol; 2003 Mar; 194(3):303-13. PubMed ID: 12548550
[TBL] [Abstract][Full Text] [Related]
5. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Medjkane S; Novikov E; Versteege I; Delattre O
Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
[TBL] [Abstract][Full Text] [Related]
8. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
Versteege I; Medjkane S; Rouillard D; Delattre O
Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
[TBL] [Abstract][Full Text] [Related]
9. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
10. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
[TBL] [Abstract][Full Text] [Related]
11. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
Caramel J; Quignon F; Delattre O
Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
[TBL] [Abstract][Full Text] [Related]
13. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1.
Neumann G; Hughes MT; Kawaoka Y
EMBO J; 2000 Dec; 19(24):6751-8. PubMed ID: 11118210
[TBL] [Abstract][Full Text] [Related]
14. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
[TBL] [Abstract][Full Text] [Related]
15. Crm1-mediated nuclear export of the Schizosaccharomyces pombe transcription factor Cuf1 during a shift from low to high copper concentrations.
Beaudoin J; Labbé S
Eukaryot Cell; 2007 May; 6(5):764-75. PubMed ID: 17384198
[TBL] [Abstract][Full Text] [Related]
16. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
[TBL] [Abstract][Full Text] [Related]
17. Integrase interactor 1 in health and disease.
Das S
Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
[TBL] [Abstract][Full Text] [Related]
18. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O
Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307
[TBL] [Abstract][Full Text] [Related]
19. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
Albanese P; Belin MF; Delattre O
Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
[TBL] [Abstract][Full Text] [Related]
20. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
